Literature DB >> 14218934

CLINICAL, PATHOLOGIC, AND SEROLOGIC STUDIES IN SJOEGREN'S SYNDROME; COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.

J J BUNIM, W W BUCHANAN, P T WERTLAKE, L SOKOLOFF, K J BLOCH, J S BECK, F P ALEPA.   

Abstract

Entities:  

Keywords:  AUTOANTIBODIES; GAMMA GLOBULIN; HODGKIN'S DISEASE; PATHOLOGY; RHEUMATOID FACTOR; SERODIAGNOSIS; SJOGREN'S SYNDROME; TOOTH ABRASION

Mesh：

Substances：

Year:  1964        PMID： 14218934     DOI： 10.7326/0003-4819-61-3-509

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

1.  Quantification of cross-reactive idiotype-positive rheumatoid factor produced in autoimmune rheumatic diseases. An indicator of clonality and B cell proliferative mechanisms.

Authors:  F Shokri; R A Mageed; G D Kitas; P Katsikis; H M Moutsopoulos; R Jefferis
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  Rheumatoid factors in cystic fibrosis: associations with disease manifestations and recurrent bacterial infections.

Authors:  M Coffey; J Hassan; C Feighery; M Fitzgerald; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

3.  Sjögren's syndrome, dysimmunoglobulinaemia and malignant disease.

Authors:  P Thomas
Journal:  Postgrad Med J       Date:  1973-05       Impact factor: 2.401

4.  [Fluorescence microscopic demonstration of antinuclear factors in lupus erythematosus and related diseases].

Authors:  K Havemann; P Arend
Journal:  Klin Wochenschr       Date:  1966-01-01

5.  Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study.

Authors:  R N MacSween; R B Goudie; J R Anderson; E Armstrong; M A Murray; D K Mason; M K Jasani; J A Boyle; W W Buchanan; J Williamson
Journal:  Ann Rheum Dis       Date:  1967-09       Impact factor: 19.103

6.  A laboratory model for Sjögren's syndrome.

Authors:  H S Kessler
Journal:  Am J Pathol       Date:  1968-03       Impact factor: 4.307

7.  Development of malignant lymphoma in myoepithelial sialadenitis (Sjögren's syndrome).

Authors:  U Schmid; D Helbron; K Lennert
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

8.  The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome.

Authors:  L G Anderson; N Talal
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

9.  Activation of peripheral blood lymphocytes in patients with primary Sjögren's syndrome.

Authors:  P Youinou; Y L Pennec; M A Blaschek; A Gentric; J Jouquan; A Lamour; P Angelidis
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

10.  Prevalence of anti-Fab antibodies in patients with autoimmune and infectious diseases.

Authors:  J Hassan; C Feighery; B Bresnihan; A Whelan
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.